Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × ONC206 × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 185 Magnetic Resonance Spectroscopy 135 Biopsy 107 pembrolizumab 105 Carboplatin 80 Nivolumab 73 Cisplatin 73 Gemcitabine 57 Cyclophosphamide 55 Radiotherapy 51 Paclitaxel 51 venetoclax 41 Bevacizumab 41 Rituximab 40 durvalumab 39 Prednisone 35 atezolizumab 34 Dexamethasone 34 X-Rays 33 Taxes 32 Radiation 32 Oxaliplatin 31 Cytarabine 30 Ipilimumab 29 Radiosurgery 28 Immunoglobulin G 28 Fluorouracil 28 Docetaxel 28 Disulfides 28 Doxorubicin 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07533942 2026-04-16

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

Jazz Pharmaceuticals

Phase 2 Not yet recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡